IR Biosciences Holdings Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRBS research report →
Price Chart
About the company
IR BioSciences Holdings, Inc. is a U. S.
- CEO
- Chet Leach D.A.B.T.
- IPO
- 2023
- Employees
- 4
- HQ
- Scottsdale, US
Get TickerSpark's AI analysis on IRBS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $128.12K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -1.06
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 47.28%
- ROIC
- 101.95%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-2,860,000
- Net Income
- $-5,278,000+18.3%
- EPS
- $-0.31+36.7%
- OCF Growth
- +85.0%
- FCF Growth
- +85.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 5.01
- RSI (14)
- 100
- Avg Volume
- 53.37K
No earnings-call transcripts are available for IRBS yet.
- Free Float
- 0.7%
- Shares Outstanding
- 2.14B
- Float Shares
- 15.59M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 19, 09 | ZELDIS JEROME B | other | 35,000 |
| Aug 19, 09 | Hariri Robert J | other | 200,000 |
| Jun 23, 09 | Hariri Robert J | other | 100,000 |
| May 28, 09 | Hariri Robert J | other | 100,000 |
| Aug 1, 07 | Hariri Robert J | other | 1,000,000 |
| Mar 31, 08 | ZELDIS JEROME B | other | 250,000 |
| Nov 26, 08 | ZELDIS JEROME B | other | 75,000 |
| Nov 1, 07 | ZELDIS JEROME B | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our IRBS coverage
Recent articles, reports, and earnings notes.
No research on IRBS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IRBS report →